二氯甲烷
谷胱甘肽
反应性(心理学)
化学
毒性
新陈代谢
氯化物
药理学
有机化学
生物化学
医学
酶
病理
替代医学
溶剂
作者
Kengo Watanabe,F. Peter Guengerich
摘要
Formyl chloride has been indirectly implicated as an intermediate in the oxidation of CH2Cl2 and proposed to be a product of the oxidation of some other compounds. Formyl chloride was synthesized and added to aqueous solutions, with CO formed as a product. The presence of glutathione (GSH) did not reduce the yield of CO at any of the pH values tested. At pH ≥ 9, a small amount of S-formyl GSH was detected (≤3% of CO formed) and identified by comparison with synthetic material using mass spectrometry. Incubations of CH2Cl2 with human liver microsomes at neutral pH produced mainly CO and only trace protein adducts (detected from 14CH2Cl2) and no S-formyl GSH at the level of detection. Neither rat liver cytosol nor purified GSH transferase (rat) 5-5 or (human) T1-1 significantly enhanced the level of S-formyl GSH recovered in incubations with either NADPH-fortified microsomes and CH2Cl2 or synthetic formyl chloride. The oxidation pathway is the principal route of metabolism of CH2Cl2 at low doses in vivo, and previous literature assumes that the formyl chloride product is reactive with GSH and protein. We provide evidence that formyl chloride can react with GSH but that, in contrast to suggestions in the literature, the extent is very limited because of the known high rate of rearrangement to CO in aqueous solution. The very limited reaction of formyl chloride with nucleophiles is consistent with the low toxicity of CH2Cl2, and formyl chloride binding cannot be used as an explanation for discrepancies in pharmacokinetic models [Gargas, M. L., Clewell, H. J., III, and Andersen, M. E. (1986) Toxicol. Appl. Pharmacol. 82, 211−223; Clewell, H. J., III (1995) Toxicology 102, 83−94].
科研通智能强力驱动
Strongly Powered by AbleSci AI